wellrank.ai
Sign In
Aveed logo

Aveed

First cited by AI Jun 12, 2026
aveedme.com

Surfaced organically in AI answers about trt and men's health. Not yet profiled.

AI Visibility

Visibility trend

TRT and men's health, daily share of AI answers mentioning Aveed, through Sep 12, 2026.

6.7%

Avg position when mentioned: 5.0 · peak 12% on Jun 17

By engine

Where Aveed is strong, and where it is invisible.

  • ChatGPT
    20.0%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 4 positive mentions
  • 73 neutral
  • 6 mixed or cautious

Recent AI answers mentioning Aveed

ChatGPTSep 12, 2026, 14:25 UTC
Enclomiphene vs TRT: which should I consider first?

Short answer If you want to preserve or improve fertility, are younger, or have low/normal LH (secondary hypogonadism), try a gonadotropin‑stimulating option (enclomiphene or the commonly used clomiphene) first. If you have primary testicular failure (high LH), are older, don’t want children, or need faster symptom relief, start testosterone replacement therapy (TRT). Why (mechanisms and typical indications) Enclomiphene / clomiphene (oral SERM): raises LH and FSH by blocking estrogen feedback at the hypothalamus/pituitary → increases your own testosterone production and usually preserves or increases sperm production. Best for secondary hypogonadism and men who want fertility. TRT (topical, injection, implant): provides exogenous testosterone to relieve symptoms quickly. It suppresses LH/FSH and commonly decreases sperm production, so it’s poor choice if you want to conceive. Pros / cons (short) Enclomiphene / clomiphene Pros: preserves/increases fertility, stimulates natural testosterone production, oral, generally well tolerated. Cons: may take weeks–months to see full benefit; not effective for primary hypogonadism; possible side effects (mood changes, visual symptoms, rare thromboembolism). Note: enclomiphene (brand Androxal) availability is limited in some places; clomiphene (Clomid) is commonly used off‑label. TRT Pros: faster symptom relief (weeks), many formulations to choose from. Cons: suppresses spermatogenesis / can cause testicular shrinking, increases hematocrit, possible PSA/benign prostatic hyperplasia effects, and other risks to monitor. Other fertility‑preserving options hCG injections (brands: Pregnyl, Novarel, or recombinant Ovidrel) stimulate testes directly and preserve/increase sperm — often used when fertility is desired or combined with TRT in some protocols. Combination care with a reproductive urologist or endocrinologist is often best. Monitoring and safety Baseline labs: total testosterone (morning), LH, FSH, prolactin, SHBG, CBC, PSA (if age appropriate), metabolic panel, sleep apnea assessment if suspected. During therapy: repeat testosterone, hematocrit, PSA, symptoms, and fertility testing if relevant. Frequency depends on therapy and provider. Practical points and specific products/services If trying a SERM: enclomiphene (Androxal) if available; otherwise clomiphene citrate (Clomid) is widely used off‑label and inexpensive. If choosing TRT: common options include topical gels (AndroGel, Testim) for convenience; short‑acting injectables (testosterone cypionate/enanthate) for cost and control; long‑acting IM (Aveed, testosterone undecanoate) or pellets (Testopel) for less frequent dosing. For fertility support: hCG brands Pregnyl/Novarel or Ovidrel (recombinant hCG). For care: see an endocrinologist or reproductive urologist for evaluation and individualized planning. Consumer telemedicine TRT services (Hims, Roman) exist for convenience but may not manage fertility needs or complex cases as well as a specialist. Next steps I suggest Get morning total testosterone plus LH/FSH, prolactin, CBC, PSA (if >40) and basic metabolic labs. Discuss goals (fertility vs symptom relief), timeline, and risks with an endocrinologist or reproductive urologist. If fertility is desired and LH is low/normal — discuss enclomiphene/clomiphene or hCG first. If primary hypogonadism or no fertility desire — discuss TRT options. If you want, tell me your age, whether you want children, recent morning testosterone and LH/FSH results (if you have them), and symptoms — I can give a more specific recommendation.

Mentioned in position 8 of 11

Read full answer with sources →
ChatGPTSep 10, 2026, 15:13 UTC
How much does TRT cost per month?

Short answer: it varies a lot. In the U.S. expect roughly $25–$2,000+ per month depending on the formulation, whether you use generic vs brand, and whether insurance covers it. Typical monthly cost ranges by formulation (approximate, out-of-pocket, U.S. retail prices): Generic injectable testosterone (cypionate or enanthate, self‑injected): $10–$60 for the medication. With supplies, lab monitoring and telemedicine/clinic fees plan you’ll commonly pay $50–$200/month total. Branded topical gels (AndroGel, Testim): $300–$700/month without insurance. Transdermal patch (Androderm): $300–$600/month. Nasal gel (Natesto): $300–$600/month. Long‑act­ing intramuscular undecanoate (Aveed/Nebido): large, infrequent injections — $800–$3,000 per injection; when spread across months this can be ~$200–$700/month. Subcutaneous pellets (Testopel): $300–$2,000 per insertion (lasts 3–6 months) → roughly $50–$650/month depending on insertion cost and frequency. Oral testosterone (Jatenzo): typically high — often $900–$2,000+/month. Other costs to factor: Initial evaluation and follow‑ups: $100–$300 per visit (varies by clinic; telemedicine can be cheaper). Lab testing (baseline and routine monitoring: total testosterone, free T, CBC, PSA, lipids, liver): $50–$300 per panel depending on insurer/discounts. Pharmacy markups, compounding pharmacy options, and mail‑order vs local pharmacy prices vary widely — use GoodRx or check insurance formularies. Insurance coverage: Many insurers will cover TRT if you meet diagnostic criteria (symptoms + documented low testosterone), but prior authorization and restrictions are common. Coverage dramatically reduces your out‑of‑pocket cost for branded products. Check with your insurer and provider. Services/brands you can consider (examples and why): Hims and Roman — telemedicine platforms that make evaluation, prescriptions, and home delivery simple; good for straightforward cases seeking convenience. Defy Medical and Vault Health — clinics/telehealth focused on men’s hormone care and ongoing monitoring; useful if you want more specialist oversight. Low T Center — in‑person clinics that commonly offer pellet therapy and quick access to treatment (variable quality; shop around). Local urologist or endocrinologist — recommended if you have complicated medical history, fertility concerns, or need specialist care. What I recommend doing next: Get baseline morning total testosterone and recommended labs (your PCP, urologist, or an online clinic can arrange this). Ask your insurer what they cover and whether prior authorization is required for specific brand names. Compare prices at local pharmacies, mail‑order, and telemedicine providers (use GoodRx or call pharmacies). If cost is the main concern, generic injectable testosterone is typically the lowest‑cost effective option. If you tell me: (a) which country you’re in and (b) whether you have insurance, I can give more specific cost estimates and suggest clinics or pharmacies to check.

Mentioned in position 5 of 14

Read full answer with sources →
ChatGPTSep 9, 2026, 15:25 UTC
What is BHRT and how do I know if I need it?

Short answer BHRT = bioidentical hormone replacement therapy. It uses hormones that are chemically identical to the ones your body makes (estradiol, progesterone, testosterone) to treat symptoms caused by low hormones — most commonly menopause/perimenopause in people assigned female at birth and low testosterone in people assigned male at birth. Whether you “need” it depends on your symptoms, medical history, lab results, and your risk tolerance after discussing benefits and risks with a clinician. What BHRT is (and what people mean by it) “Bioidentical” means the hormone molecule matches human hormones (for example, 17β‑estradiol and micronized progesterone). Several FDA‑approved products use bioidentical hormones. BHRT can be given as pills, patches, gels, creams, rings, injections, or implanted pellets. There are two common uses: Menopause/perimenopause symptom relief (hot flashes, night sweats, vaginal dryness, mood/sleep problems). Treatment of clinically proven low testosterone in men (low energy, low libido, low muscle mass) or selected women in specialist care. Important distinction: FDA‑approved bioidentical hormone products (with consistent dosing and tested safety/efficacy) versus compounded BHRT (custom formulations from compounding pharmacies). Compounded products are not FDA‑approved and have variable dosing and quality. Potential benefits Effective relief of hot flashes, night sweats, vaginal dryness, and improved sleep, mood and quality of life for many people in menopause. Testosterone therapy can improve libido, energy and muscle mass in men with confirmed low testosterone. Potential risks and caveats Hormone therapy has risks: increased risk of blood clots, stroke, and (depending on type/duration) possibly breast cancer and gallbladder disease. Risks vary by age, dose, route, and whether progesterone is used with estrogen in people with a uterus. Compounded BHRT lacks large long‑term safety data and quality control compared with FDA‑approved products. Some delivery methods (pellets) have limited long‑term safety data and may be harder to dose or remove quickly. How to know if you need BHRT — practical steps Assess symptoms: keep a brief log of symptoms (hot flashes, sleep loss, vaginal symptoms, libido, mood, energy). Severity and effect on quality of life matter. See a clinician: primary care, OB/GYN, endocrinologist or men’s health/urology if male. A menopause specialist is ideal for complicated cases. Get an appropriate workup: For people with menopausal symptoms: history, physical exam, and—if needed—labs such as FSH (to confirm menopause in younger people), estradiol sometimes, and baseline screening (mammogram as recommended by age, lipid and metabolic screens as appropriate). For suspected low testosterone in men: at least two morning total testosterone levels, plus free testosterone if needed, and evaluation of causes; baseline PSA and hematocrit before and during therapy. Avoid relying on commercial salivary or urine “hormone” panels for diagnosis — blood tests interpreted by a clinician are standard. Review contraindications: active or recent estrogen‑dependent breast cancer, active blood clots or high clotting risk, uncontrolled cardiovascular disease or stroke risk, and some liver diseases are important reasons to avoid or modify therapy. Discuss options: nonhormonal treatments (SSRIs/SNRIs, gabapentin, lifestyle measures, vaginal moisturizers/lubricants, ospemifene for vaginal symptoms) may be alternatives for some people. If you choose hormone therapy, prefer FDA‑approved bioidentical products when possible (known dosing, manufacturing standards) and use the lowest effective dose for the shortest necessary time with regular follow‑up. Brands and services (examples and why) Estradiol patches/gels: Vivelle‑DOT, Climara (patches), EstroGel/Divigel (gels). Why: FDA‑approved, consistent dosing and widely used for menopausal symptoms. Oral progesterone: Prometrium (micronized progesterone). Why: FDA‑approved bioidentical progesterone (used for uterine protection when estrogen is given to people with a uterus). Vaginal estrogen: Estring, Vagifem (rings/tablets) or estradiol creams. Why: localized relief for vaginal dryness with low systemic absorption. Testosterone (men): AndroGel, Testim, Depo‑Testosterone (injections), Aveed. Why: FDA‑approved options with established dosing and monitoring standards. If considering compounded BHRT: use a compounding pharmacy accredited by the Pharmacy Compounding Accreditation Board (PCAB) and only under a clinician who will monitor you closely. Reputable resources and clinics: The North American Menopause Society (NAMS) for guidelines; large centers like Mayo Clinic or Cleveland Clinic have menopause programs and evidence‑based counseling. When to see a specialist right away Severe symptoms that interfere with daily life. Young people with early menopause/POI (premenopausal people in their 40s or younger). Complex medical history (history of breast cancer, blood clots, stroke, or serious heart disease). Considering long‑term testosterone in women or specialized compounded regimens. Bottom line BHRT can be very effective for hormone‑deficiency symptoms, but it isn’t automatically the right choice for everyone. Start by documenting symptoms, get evaluated by a clinician, have appropriate blood tests, review risks and benefits, and prefer FDA‑approved formulations unless there’s a clear, monitored reason to use compounded BHRT. If you want, tell me your age, sex assigned at birth, main symptoms, and any major medical history (breast cancer, blood clots, heart disease) and I can suggest which tests to ask for and what type of specialist to see.

Mentioned in position 10 of 12

Read full answer with sources →
ChatGPTSep 8, 2026, 15:21 UTC
How quickly does TRT work for energy and libido?

Short answer Many men notice increased libido within 1–3 weeks of starting TRT, with clearer improvement by 4–6 weeks. Energy and fatigue often improve a bit later: some benefit by 3–4 weeks, more noticeable by 6–12 weeks. Full sexual, mood and energy benefits commonly take 3–6 months and can continue to evolve after that. Why timing varies Baseline testosterone level, age, overall health, sleep, depression, medications, and whether erectile dysfunction has a vascular/neurologic cause all affect speed and degree of response. Route and dosing matter: injections often produce quicker rises in blood testosterone than daily gels; gels and long‑acting injections produce steadier levels. TRT improves sexual desire (libido) more reliably than erection quality; ED from blood‑flow problems may need additional treatments (PDE5 inhibitors). Typical timelines by symptom Libido (sexual desire): first signs 1–3 weeks; meaningful improvement by 4–6 weeks; many men reach good improvement by 3 months. Energy / fatigue: subtle changes in 3–4 weeks; clearer benefit by 6–12 weeks. Erectile function: often slower and less predictable — may take months and sometimes requires combination therapy (e.g., Viagra/Cialis). Mood, concentration, muscle mass, bone density: changes over months (3–12+ months). Route differences (practical note) Intramuscular injections (testosterone cypionate/enanthate like Depo‑Testosterone): rapid rises after injection; dosing weekly or every 1–2 weeks. Long‑acting injections (testosterone undecanoate like Aveed/Nebido): steadier levels over many weeks/months. Topical gels (AndroGel, Testim, Axiron, Fortesta): daily application, steady dosing; libido improvements often appear early once levels rise. Pellets (Testopel): slow steady release over months. Safety, monitoring, and important cautions Baseline tests before starting: morning total testosterone, CBC (hematocrit), PSA, CMP/liver tests, and often LH/FSH; consider sperm count if fertility matters. Recheck testosterone and hematocrit about 4–12 weeks after starting or dose change, then every 3–6 months initially. Common side effects: increased hematocrit, acne, fluid retention, decreased testicular size and sperm production, possible worsening of sleep apnea, and small risk signals for prostate issues. If you want children, TRT (exogenous testosterone) often suppresses sperm production — alternatives include clomiphene citrate or hCG to raise testosterone while preserving fertility. What you can do now Get morning (7–10 AM) total testosterone and relevant baseline labs. Discuss with a clinician whether TRT is appropriate and which form fits your goals/lifestyle. If erection problems persist, ask about adding a PDE5 inhibitor. Services/brands you might consider Depot/injectables: Depo‑Testosterone (testosterone cypionate) — widely used, flexible dosing. Aveed (testosterone undecanoate) / Nebido — long‑acting injections for less frequent dosing. Topicals: AndroGel, Testim, Axiron — daily gels with predictable absorption for many men. Pellets: Testopel — useful if you prefer infrequent procedures. Telemedicine/men’s health services: Vault Health (more comprehensive testing and follow‑up), Roman and Hims (convenient telemedicine and delivery). These can be good for access, but for complex cases or fertility concerns see an endocrinologist/urologist. When to see a specialist If you have a history of prostate cancer, known fertility desires, abnormal baseline labs, significant heart disease, or complex symptoms — see an endocrinologist or urologist experienced in male hormonal care. If you want, tell me: your age, recent morning testosterone level (if available), and whether you want children — I can give more tailored expectations and next steps.

Mentioned in position 2 of 11

Read full answer with sources →
ChatGPTSep 7, 2026, 16:43 UTC
Enclomiphene vs TRT: which should I consider first?

Short answer If you want to preserve or improve fertility (or want to keep testicular size/function) — try a fertility-preserving approach first (enclomiphene or the more widely available clomiphene, or hCG), not standard TRT. If you do NOT want future fertility and you have symptomatic low testosterone — standard TRT is usually the first-line treatment. Why (key differences) Mechanism: TRT gives exogenous testosterone and reliably raises serum T but suppresses LH/FSH → usually reduces sperm production. Enclomiphene (a SERM) stimulates the pituitary to raise LH/FSH and therefore increases the body’s own testosterone production without the same suppression of sperm. Fertility: Enclomiphene/clomiphene or hCG preserves or improves spermatogenesis; TRT usually reduces it. Onset and effect: TRT gives predictable symptom relief and steady T levels. Enclomiphene/clomiphene can take several weeks and may be less predictable in some men, especially if testes are failing. Cause matters: If you have primary hypogonadism (high LH/FSH), stimulating the pituitary won’t help — TRT is appropriate. If you have secondary hypogonadism (low/normal LH/FSH) and intact testes, a pituitary-stimulating approach can work. Practical steps I recommend Get a proper evaluation before choosing: two morning total testosterone measurements, LH, FSH, prolactin, SHBG (if available), CBC, PSA (if age-appropriate), metabolic panel, and a semen analysis if fertility matters. Decide based on desire for children and lab pattern: Desire fertility + secondary hypogonadism → consider enclomiphene or clomiphene citrate (off-label) or hCG therapy. No fertility desire or primary hypogonadism → consider TRT. If you’re taking opioids, have untreated sleep apnea, obesity, or certain meds — treat those causes first; hypogonadism can be reversible. Follow-up & monitoring: check symptoms and labs at baseline and periodically (testosterone, hematocrit/hemoglobin, PSA, lipids, LFTs; semen analysis if relevant). Medications/brands and why (examples) Enclomiphene: Androxal (enclomiphene citrate) — designed to raise endogenous T while preserving fertility; availability may be limited depending on country/clinic and insurance. Clomiphene citrate: Clomid — not enclomiphene but commonly used off-label for the same purpose; widely available and inexpensive. Good option if enclomiphene is not accessible. hCG injections: Pregnyl, Ovidrel, Novarel — used to maintain spermatogenesis or testicular size; commonly used either alone or with TRT in men who want fertility. TRT (injections): Depo‑Testosterone (testosterone cypionate) — common, inexpensive intramuscular option. Aveed (testosterone undecanoate) — very long‑acting with fewer injections but requires in‑clinic dosing and has special safety considerations. TRT (gels/solutions): AndroGel, Testim, Fortesta, Axiron — convenient daily topical options with steady dosing but possible skin transfer to others. Risks and contraindications to consider TRT: erythrocytosis (raised hematocrit), acne, reduced sperm count/testicular atrophy, potential risks in men with prostate cancer (active disease is a contraindication), and possible CV risks in some men — discuss with your clinician. Enclomiphene/clomiphene: possible mood changes, visual symptoms (rare), and not effective if testes are unresponsive (primary hypogonadism). Availability/cost may be issues. When to see a specialist If you want to preserve fertility or are planning conception — see a reproductive urologist or endocrinologist experienced in male fertility. If labs are abnormal or you have complex comorbidity (history of prostate cancer, very low T, erythrocytosis, or unclear cause) — see an endocrinologist or urologist. If you want, tell me: Your age, whether you want kids now or in the future, recent morning testosterone and LH/FSH values (if available), and symptoms — I can give a more tailored suggestion and a practical next step to take to your clinician.

Mentioned in position 7 of 11

Read full answer with sources →
ChatGPTSep 5, 2026, 14:05 UTC
What are the risks and side effects of starting TRT in your 30s?

Short answer: Testosterone replacement therapy (TRT) can effectively treat true testosterone deficiency, but starting it in your 30s carries important risks — especially for fertility — plus potential cardiovascular, hematologic, prostate and mood/skin effects. Many risks can be reduced with proper evaluation, formulation choice, and monitoring. Talk with an endocrinologist or urologist before starting. Key risks and side effects Infertility / testicular atrophy (most important in your 30s) Exogenous testosterone suppresses LH/FSH → reduced sperm production and often smaller testes. This effect can start within months and is often reversible after stopping, but recovery can take many months to years and is not guaranteed. If you want biological kids, avoid starting standard TRT without fertility-preserving strategies. Reduced sperm count alternatives Use treatments that stimulate endogenous testosterone (clomiphene, hCG) or add hCG while on TRT to preserve spermatogenesis. Polycythemia (high hematocrit) TRT can raise red blood cell mass, increasing risk of blood clots, stroke, and heart attack. Hematocrit >54% is an important cutoff that often triggers dose change or phlebotomy. Cardiovascular events Data are mixed. Some studies show no increased risk in younger men; other studies suggest possible increased risk in men with existing cardiac disease. Individual risk factors matter. Prostate effects TRT can raise PSA and may unmask existing prostate cancer. Absolute prostate cancer risk increase is not clearly proven, and TRT is contraindicated in men with untreated prostate cancer. Sleep apnea TRT can worsen or unmask obstructive sleep apnea. Breast/tissue changes Gynecomastia due to aromatization to estrogens is possible. Mood and behavior Can improve mood and libido for many, but may cause irritability, aggression, or mood swings in some. Skin and hair Acne and increased facial/body oiliness; possible acceleration of male pattern baldness in genetically predisposed men. Liver toxicity Rare with modern gels/injections; more a concern with older oral anabolic steroids. Commitment and long-term unknowns Many men need lifelong therapy; long-term effects of decades of TRT starting in young adulthood are still not fully defined. Evaluation and monitoring (typical) Baseline: total testosterone (morning, ideally two measurements), free T, LH, FSH, prolactin, estradiol, CBC (hematocrit/Hb), lipid panel, PSA (if age-appropriate), CMP/LFTs, and consider baseline semen analysis if fertility matters. Measure weight/BP and screen for sleep apnea if indicated. After starting: check labs ~6–12 weeks after initiation or dose change (testosterone level, hematocrit, estradiol), then every 3–6 months for the first year, then 6–12 months ongoing. Monitor PSA and digital rectal exam per urology/endocrinology guidance. Targets/thresholds: Avoid hematocrit >54%; many clinicians aim for mid-normal testosterone range rather than supraphysiologic levels. Fertility-preserving options if you’re in your 30s If you want kids, consider: Avoid standard TRT and use alternatives such as clomiphene citrate (Clomid) to stimulate pituitary LH/FSH and raise endogenous T while preserving spermatogenesis. Human chorionic gonadotropin (hCG) injections (e.g., Ovidrel or prescribed hCG formulations) can maintain intratesticular testosterone and sperm production; can be used alone or with TRT. Enclomiphene (when available) is a related option that raises endogenous T. Sperm banking prior to TRT if immediate parenthood isn’t necessary. Discuss combination protocols with a specialist if you need symptom control but also want fertility. Formulations and practical points (how some differ) Injectable (short-acting enanthate/cypionate, longer-acting undecanoate/Aveed) — injections commonly given every 1–3 weeks or every 10–14 weeks for Aveed; injectable dosing affects mood variability and troughs/peaks. Topical gels (AndroGel, Testim, Fortesta) — daily, avoid skin-to-skin transfer risks. Patches (Androderm) — daily patch, skin irritation is possible. Pellets (Testopel) — implanted subcutaneously every few months, surgical procedure required. Brands/services (examples you may encounter) Testosterone preparations: AndroGel (topical), Testim (topical), Androderm (patch), Depo-Testosterone/testosterone cypionate (injectable), Aveed (testosterone undecanoate, long-acting IM), Testopel (pellets). Choice depends on tolerance, convenience, and monitoring. Fertility-preserving alternatives: Clomid (clomiphene citrate) — off-label for men to raise endogenous T; hCG injections (prescribed formulations/Ovidrel for hCG). Telemedicine/direct-to-consumer clinics: Hims, Roman, Vault Health — they offer online evaluation and monitoring but quality varies; for complex issues or fertility concerns, see an endocrinologist or reproductive urologist in person. Labs/monitoring: Quest Diagnostics, Labcorp for routine testing. Sperm banking: California Cryobank, Fairfax Cryobank — if preserving fertility. Who should NOT start TRT Men with untreated prostate or breast cancer, uncontrolled polycythemia, or uncontrolled severe heart failure/active cardiovascular instability generally should not start TRT until cleared by a specialist. Next steps I recommend Get a proper evaluation: repeat morning testosterone measurements plus LH/FSH, prolactin, estradiol and baseline CBC/PSA if appropriate. If fertility matters, get a semen analysis and discuss alternatives (clomiphene, hCG, or sperm banking) before starting TRT. See an endocrinologist or urologist experienced in male reproductive health; if you use a telemedicine service, ensure they provide the full baseline testing and structured follow-up. If you start TRT, commit to the monitoring schedule above and report new symptoms (chest pain, severe headaches, shortness of breath, visual changes, sudden swelling, significant mood changes). If you want, tell me: your baseline testosterone values and symptoms, whether you want children in the future, any medical history (cardiac disease, sleep apnea, prostate issues), and I can give more tailored guidance about options and what tests to get next.

Mentioned in position 8 of 16

Read full answer with sources →

TL;DR

Aveed is a prescription testosterone replacement therapy (TRT) product made by Endo Pharmaceuticals, offered as a long-acting injectable formulation of testosterone undecanoate for men with hypogonadism. It is administered in a clinical setting rather than self-injected at home, which sets it apart from many competing products. In WellRank's latest AI-answer index, Aveed ranks fifteenth in the TRT and men's health category with roughly 10 percent visibility, appearing in AI responses most often in neutral, informational contexts alongside brands such as AndroGel and Depo-Testosterone.

Company Overview

Aveed is a branded prescription medication developed and marketed by Endo Pharmaceuticals, a specialty pharmaceutical company. The product is not a telehealth platform itself but is prescribed through physicians and administered in certified healthcare settings due to a required REMS (Risk Evaluation and Mitigation Strategy) program mandated by the FDA. The business model is a traditional pharmaceutical one, relying on physician prescribing and insurance reimbursement rather than direct-to-consumer retail or subscription.

Product Features

  • Long-acting injectable testosterone undecanoate requiring only a small number of injections per year compared to weekly or biweekly alternatives
  • In-office or clinic-administered injection, eliminating the need for patient self-injection
  • FDA-approved treatment specifically for male hypogonadism (low testosterone due to a medical condition)
  • Subject to a mandatory REMS program because of a risk of serious pulmonary oil microembolism and anaphylaxis reactions
  • Sustained testosterone levels designed to reduce peaks and troughs common with shorter-acting injectables

Target Market

Aveed is indicated for adult men diagnosed with hypogonadism, a condition in which the body does not produce sufficient testosterone due to a primary or secondary medical cause. It is prescribed within the United States, where it holds FDA approval, and is distributed through certified healthcare providers who meet REMS requirements. It is not intended for men seeking testosterone therapy solely for age-related decline without a confirmed clinical diagnosis.

Buyer Personas

  • A man in his 40s or 50s with a physician-confirmed hypogonadism diagnosis who prefers infrequent clinic visits over daily gels or weekly self-injections.
  • A urologist or endocrinologist patient who values a long-acting, professionally administered therapy and wants to minimize dosing complexity.
  • A man who has tried topical testosterone products and experienced skin-transfer concerns or inconsistent absorption and is now exploring injectable alternatives.
  • A patient with employer-sponsored insurance seeking an FDA-approved branded therapy that may be covered under a prescription drug plan.

Funding & Performance

Aveed is a commercial prescription product of Endo Pharmaceuticals, which has been a publicly traded and subsequently restructured specialty pharma company. Specific revenue figures attributable to Aveed alone are not publicly disclosed as a standalone line item.

Recent Developments

Aveed has maintained its position as one of the few FDA-approved long-acting injectable testosterone therapies in the United States. Endo Pharmaceuticals has undergone significant corporate restructuring in recent years, which is widely reported, though the impact on Aveed's commercial operations has not been detailed publicly. The product continues to be available through its REMS-certified provider network, and prescribing and safety information is maintained on the brand's official site.

Competitive Landscape

According to WellRank's co-mention data, AI engines most frequently place Aveed alongside AndroGel, Testim, Depo-Testosterone, Testopel, and Androderm when discussing prescription TRT options, as well as telehealth-native brands like Roman and Hims. Aveed's primary differentiator from topical competitors such as AndroGel and Androderm is its injectable, long-acting format, while it competes with Testopel pellets and Depo-Testosterone injections on the injectable side. The rise of telehealth TRT providers like Roman and Hims represents a distinct competitive pressure, as those platforms offer more accessible, subscription-style access to testosterone therapy, whereas Aveed requires in-person clinical administration.

Aveed vs the brands AI recommends alongside it

The real competitive set in TRT and men's health: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Aveed logo
AveedThis brand
#25
6.7%
AndroGel logo
AndroGel

80 shared answers

#11
15.6%
Testim logo
Testim

78 shared answers

#20
11.1%
Depo-Testosterone logo
Depo-Testosterone

65 shared answers

#36
4.4%
Roman logo
Roman

57 shared answers

#3
28.9%

Email me when overtakes Aveed

One email the day the ranks flip. Nothing else.

User Sentiment

WellRank's corpus of 55 AI mentions of Aveed shows that the overwhelming majority, 48 out of 55, are neutral and informational in tone, consistent with how AI engines tend to describe a prescription pharmaceutical with a specific risk profile and clinical-use requirement. Only two mentions are clearly positive, and five are characterized as mixed or cautious, likely reflecting the REMS program requirements and the serious adverse reaction warnings that appear in clinical references. Public patient discussion tends to focus on the convenience of fewer injections weighed against the requirement to visit a clinic for each dose.

Pricing

Aveed is a branded prescription medication and its cost to patients varies significantly depending on insurance coverage, pharmacy benefit manager negotiations, and patient assistance program eligibility. A list price exists but out-of-pocket cost is highly variable and not meaningfully summarized as a single figure; patients are typically advised to check with their insurer or use Endo's patient support resources.

Sources cited around Aveed

The sites engines cite in answers mentioning this brand. Win these, win the answer.

    Track Aveed weekly

    One email a week: rank moves, new competitors, and the answers that changed. No noise.

    Work at Aveed? Get your AI Visibility Audit.

    See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.